334 related articles for article (PubMed ID: 21534088)
1. Non-neoplastic and neoplastic pleural endpoints following fiber exposure.
Broaddus VC; Everitt JI; Black B; Kane AB
J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):153-78. PubMed ID: 21534088
[TBL] [Abstract][Full Text] [Related]
2. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.
Huang SX; Jaurand MC; Kamp DW; Whysner J; Hei TK
J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):179-245. PubMed ID: 21534089
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.
Mossman BT; Lippmann M; Hesterberg TW; Kelsey KT; Barchowsky A; Bonner JC
J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):76-121. PubMed ID: 21534086
[TBL] [Abstract][Full Text] [Related]
4. Factors that impact susceptibility to fiber-induced health effects.
Below JE; Cox NJ; Fukagawa NK; Hirvonen A; Testa JR
J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):246-66. PubMed ID: 21534090
[TBL] [Abstract][Full Text] [Related]
5. [Pleural lymphatics and pleural diseases related to fibres].
Fleury Feith J; Jaurand MC
Rev Pneumol Clin; 2013 Dec; 69(6):358-62. PubMed ID: 24210155
[TBL] [Abstract][Full Text] [Related]
6. Asbestos: when the dust settles an imaging review of asbestos-related disease.
Roach HD; Davies GJ; Attanoos R; Crane M; Adams H; Phillips S
Radiographics; 2002 Oct; 22 Spec No():S167-84. PubMed ID: 12376609
[TBL] [Abstract][Full Text] [Related]
7. Mesothelioma and analysis of tissue fiber content.
Neumann V; Löseke S; Tannapfel A
Recent Results Cancer Res; 2011; 189():79-95. PubMed ID: 21479897
[TBL] [Abstract][Full Text] [Related]
8. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
[TBL] [Abstract][Full Text] [Related]
9. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure.
McConnell EE; Axten C; Hesterberg TW; Chevalier J; Miiller WC; Everitt J; Oberdörster G; Chase GR; Thevenaz P; Kotin P
Inhal Toxicol; 1999 Sep; 11(9):785-835. PubMed ID: 10477659
[TBL] [Abstract][Full Text] [Related]
10. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma.
Donaldson K; Murphy FA; Duffin R; Poland CA
Part Fibre Toxicol; 2010 Mar; 7():5. PubMed ID: 20307263
[TBL] [Abstract][Full Text] [Related]
11. Translocation pathways for inhaled asbestos fibers.
Miserocchi G; Sancini G; Mantegazza F; Chiappino G
Environ Health; 2008 Jan; 7():4. PubMed ID: 18218073
[TBL] [Abstract][Full Text] [Related]
12. Global use of asbestos and the incidence of mesothelioma.
Tossavainen A
Int J Occup Environ Health; 2004; 10(1):22-5. PubMed ID: 15070022
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of mesothelioma induction with asbestos and fibrous glass.
Stanton MF; Wrench C
J Natl Cancer Inst; 1972 Mar; 48(3):797-821. PubMed ID: 5058974
[No Abstract] [Full Text] [Related]
14. Pulmonary toxicity of carbon nanotubes and asbestos - similarities and differences.
Donaldson K; Poland CA; Murphy FA; MacFarlane M; Chernova T; Schinwald A
Adv Drug Deliv Rev; 2013 Dec; 65(15):2078-86. PubMed ID: 23899865
[TBL] [Abstract][Full Text] [Related]
15. Asbestos fiber length and its relation to disease risk.
Barlow CA; Grespin M; Best EA
Inhal Toxicol; 2017; 29(12-14):541-554. PubMed ID: 29458304
[TBL] [Abstract][Full Text] [Related]
16. Morphological and chemical mechanisms of elongated mineral particle toxicities.
Aust AE; Cook PM; Dodson RF
J Toxicol Environ Health B Crit Rev; 2011; 14(1-4):40-75. PubMed ID: 21534085
[TBL] [Abstract][Full Text] [Related]
17. Asbestos-induced pleural disease.
Nishimura SL; Broaddus VC
Clin Chest Med; 1998 Jun; 19(2):311-29. PubMed ID: 9646983
[TBL] [Abstract][Full Text] [Related]
18. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?
Sanchez VC; Pietruska JR; Miselis NR; Hurt RH; Kane AB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):511-29. PubMed ID: 20049814
[TBL] [Abstract][Full Text] [Related]
19. Tumor incidence was not related to the thickness of visceral pleural in female Syrian hamsters intratracheally administered amphibole asbestos or manmade fibers.
Adachi S; Kawamura K; Kimura K; Takemoto K
Environ Res; 1992 Jun; 58(1):55-65. PubMed ID: 1317792
[TBL] [Abstract][Full Text] [Related]
20. Environmental asbestos-related pleural plaque in southeast of Turkey.
Ates G; Yildiz T; Akyildiz L; Topcu F; Erturk B
Arch Environ Occup Health; 2010; 65(1):34-7. PubMed ID: 20147001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
